Anti-Mycobacterium tuberculosis Ag85 antibody [HYT27]
2
(2 Reviews)
|
(10 Publications)
Mouse Monoclonal TB Ag85A antibody. Suitable for ELISA, WB and reacts with Mycobacterium tuberculosis samples. Cited in 10 publications. Immunogen corresponding to Cell preparation containing Mycobacterium tuberculosis Ag85 protein.
View Alternative Names
mpt44, Rv3804c, MTV026.09c, fbpA, Diacylglycerol acyltransferase/mycolyltransferase Ag85A, DGAT, Acyl-CoA:diacylglycerol acyltransferase, Antigen 85 complex A, Fibronectin-binding protein A, 85A, Ag85A, Fbps A
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The Ag85 complex facilitates the synthesis and transfer of mycolic acids essential constituents of the mycobacterial cell wall's lipid-rich structure. The Ag85 proteins participate in forming this barrier allowing Mycobacterium tuberculosis to resist host immune defenses. This functionality is linked to its involvement in the mycolyltransferase enzyme system which operates in collaboration with several other proteins necessary for full cell wall biosynthesis.
Pathways
The Ag85 complex significantly contributes to the biosynthetic route of mycolic acids an integral component of mycobacterial cell walls. This pathway includes interactions with other proteins like Pks13 and Mycobacterial arabinosyltransferase (EmbB) both important for the complex architectural integrity and viability of the mycobacterial cell wall. This biosynthesis pathway ensures proper assembly and maintenance of the cell envelope enhancing the persistence of the bacteria.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Nature microbiology 8:803-818 PubMed36959508
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:1430 PubMed36932056
2023
Applications
Unspecified application
Species
Unspecified reactive species
Advanced healthcare materials 11:e2200589 PubMed35678244
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34558650
2021
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 17:e1009410 PubMed33720986
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 10:1973 PubMed31036822
2019
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 10:e1004183 PubMed24874799
2014
Applications
WB
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of 105:264-9 PubMed18172199
2008
Applications
WB
Species
Unspecified reactive species
Infection and immunity 55:2922-7 PubMed3119491
1987
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical microbiology 23:446-51 PubMed2420818
1986
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com